HTBX - Heat Biologics added to Russell Microcap Index

At the conclusion of the annual Russell indexes reconstitution, US clinical-stage biopharmaceutical company Heat Biologics (HTBX) will join the Russell Microcap Index.The move is effective June 28, 2021 after the US market opens. Heat Biologics Chief Executive Officer Jeff Wolf commented, "Joining this index is a reflection of the progress we have made this year in our clinical programs, including both our oncology program and COVID-19 vaccine program, building a strong balance sheet with over $132 million of cash and short-term investments as of Q1 2021 and increasing shareholder value."Previously (June 23): Heat Biologics announced the expansion of its research and development facilities in Morrisville, North Carolina. Shares up +1.80 premarket.Press Release

For further details see:

Heat Biologics added to Russell Microcap Index